Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.69 |
| ▸ | TTR | P02766 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | APP | P05067 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.69 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.69 |
| ▸ | DPP4 | P27487 | 2/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.69 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.69 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1314851 | 1.00 | KDM4E (0.69) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL29773361 | 1.00 | KDM4E (0.69) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| Phenol SCHEMBL28949254 | 0.90 | MMP1 (0.62) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL2221673 | 0.83 | KDM4E (0.74) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL5598948 | 0.83 | KDM4E (0.74) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL30740005 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL30739974 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL21986709 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL30740008 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL21986714 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4228667-A1 | METHODS FOR REVERSING HEPATIC STEATOSIS | Brightseed, Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| EP-4003060-A1 | METHOD FOR IMPROVING DIGESTIVE HEALTH | Brightseed, Inc. (US) | 2022-06-01 | — | — | EP | claimed |
| WO-2022081567-A1 | METHODS FOR REVERSING HEPATIC STEATOSIS | BRIGHTSEED, INC. (US) | 2022-04-21 | — | — | WO | claimed |
| JP-2104568-A | — | — | None | — | — | JP | disclosed |
| US-20260102332-A1 | Enhanced Toothpaste And Kits | BEAUTYPASTE INC. (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4465976-A1 | USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION | Brightseed, Inc. (US) | 2024-11-27 | — | — | EP | disclosed |
| US-11801216-B2 | Enhanced toothpaste and kits | BEAUTYPASTE INC. (US) | 2023-10-31 | — | — | US | disclosed |
| WO-2023141427-A1 | USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION | BRIGHTSEED, INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| CN-115536604-A | Caffeic acid amide compound and application thereof | 广西大学 | 2022-12-30 | — | — | CN | disclosed |
| CN-115536604-A | Caffeic acid amide compound and application thereof | 广西大学 | 2022-12-30 | — | — | CN | disclosed |
| EP-4025181-A1 | ENHANCED TOOTHPASTE AND KITS | Beautypaste LLC (US) | 2022-07-13 | — | — | EP | disclosed |
| US-8912332-B2 | Synthesis of trivalent flexible frameworks with ligands comprising catechol units for functionalizing surfaces | JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) | 2014-12-16 | — | — | US | disclosed |
| EP-2428502-B1 | Synthesis of tripodal catechol derivatives with an adamantyl base for functionalising surfaces | Justus Liebig Universität Giessen (DE) | 2014-12-10 | — | — | EP | disclosed |
| US-20140357678-A1 | COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) (AR) | 2014-12-04 | — | — | US | disclosed |
| CN-103012181-B | Method for compounding caffeoyl dopamine | SUZHOU UUGENE BIOPHARMA CO LTD | 2014-06-04 | — | — | CN | disclosed |
| US-20130245270-A1 | Synthesis of Trivalent Flexible Frameworks with Ligands Comprising Catechol Units for Functionalizing Surfaces | JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) | 2013-09-19 | — | — | US | disclosed |
| CN-103012181-A | Method for compounding caffeoyl dopamine | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-04-03 | — | — | CN | disclosed |
| CN-1646480-A | Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition | MOGAM BIOTECH RES INST (KR) | 2005-07-27 | — | — | CN | disclosed |
| US-5681708-A | DISSOCIATE PROTEIN-PROTEIN COMPLEX | SMITHKLINE BEECHAM CORPORATION (US) | 1997-10-28 | — | — | US | disclosed |
| JP-H02104568-A | ACTING AGENT OF PRODUCTION PROMOTION OF NERVE GROWTH FACTOR | YOSHITOMI PHARMACEUT IND LTD | 1990-04-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245270-A1 | Synthesis of Trivalent Flexible Frameworks with Ligands Comprising Catechol Units for Functionalizing Surfaces | CHRM3, CHRM5, CHRM4 | KDM4E 1565/4885MAPT 4034/4885TTR 1485/4885 |
| US-20260102332-A1 | Enhanced Toothpaste And Kits | TAS2R10, CENPE, TAS2R30 | KDM4E 2025/4885MAPT 3718/4885TTR 2262/4885 |
| US-20140357678-A1 | COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | C5, CBR3, C1R | KDM4E 2424/4885MAPT 4222/4885TTR 3703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.